有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S)-N-[(3R)-1,1-dioxothiolan-3-yl]-2-(4-fluorophenyl)sulfanyl-N-methylpropanamide | —— | C14H18FNO3S2 |
|
—— | (2S)-N-[(2-chlorophenyl)methyl]-2-(4-fluorophenyl)sulfanylpropanamide | —— | C16H15ClFNOS |
|
—— | (2S)-N-[(3S)-1,1-dioxothiolan-3-yl]-2-(4-fluorophenyl)sulfanylpropanamide | —— | C13H16FNO3S2 |
|
—— | (2R)-N-[(2-chlorophenyl)methyl]-2-(4-fluorophenyl)sulfanylpropanamide | —— | C16H15ClFNOS |
|
—— | (2R)-N-[(3S)-1,1-dioxothiolan-3-yl]-2-(4-fluorophenyl)sulfanylpropanamide | —— | C13H16FNO3S2 |
|
—— | (2S)-N-(1-cyanocyclohexyl)-2-(4-fluorophenyl)sulfanyl-N-methylpropanamide | —— | C17H21FN2OS |
|
—— | (2R)-N-(1-cyanocyclohexyl)-2-(4-fluorophenyl)sulfanyl-N-methylpropanamide | —— | C17H21FN2OS |
|
—— | (2R)-N-[(3S)-1,1-dioxothiolan-3-yl]-2-(4-fluorophenyl)sulfanyl-N-methylpropanamide | —— | C14H18FNO3S2 |
|
—— | (2S)-N-[(4-fluorophenyl)methyl]-2-(4-fluorophenyl)sulfanylpropanamide | —— | C16H15F2NOS |
|
—— | (2R)-N-[(4-fluorophenyl)methyl]-2-(4-fluorophenyl)sulfanylpropanamide | —— | C16H15F2NOS |
|
—— | (2S)-N-[(3S)-1,1-dioxothiolan-3-yl]-2-(4-fluorophenyl)sulfanyl-N-methylpropanamide | —— | C14H18FNO3S2 |
|
—— | (2R)-N-[(3R)-1,1-dioxothiolan-3-yl]-2-(4-fluorophenyl)sulfanylpropanamide | —— | C13H16FNO3S2 |
|
—— | (2S)-N-[(4-methylphenyl)methyl]-2-[(4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C16H20N4OS |
|
—— | (2S)-N-[(4-fluorophenyl)methyl]-2-[(4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C15H17FN4OS |
|
—— | (2R)-N-(2-phenylsulfanylphenyl)-2-[(4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]propanamide | —— | C20H20N4OS2 |
|
—— | (2R)-N-(1-cyanocyclohexyl)-2-[(5-cyclohexyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]-N-methylpropanamide | —— | C22H33N5OS |
|
—— | (2R)-2-[(5-cyclohexyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]-N-(2-phenylethyl)propanamide | —— | C22H30N4OS |
|
—— | (2S)-N-(1-cyanocyclohexyl)-2-[(5-cyclohexyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]-N-methylpropanamide | —— | C22H33N5OS |
|
—— | [(2R)-1-oxo-1-(2-phenylsulfanylanilino)propan-2-yl] 4-(hydroxymethyl)benzoate | —— | C23H21NO4S |
|
—— | (2R)-2-(4-cyclopentylsulfanylphenyl)-2-(furan-2-yl)ethanamine | —— | C17H21NOS |
|
—— | (2R)-2-(3,4-dimethylphenyl)sulfanyl-N-[(3R)-1,1-dioxothiolan-3-yl]-N-ethylpropanamide | —— | C17H25NO3S2 |
|
—— | (2S)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methylpropyl)propanamide | —— | C15H18BrN3O2S |
|
—— | (2S)-2-(4-cyclopentylsulfanylphenyl)-2-(furan-2-yl)ethanamine | —— | C17H21NOS |
|
—— | (2S)-2-(3,4-dimethylphenyl)sulfanyl-N-[(3R)-1,1-dioxothiolan-3-yl]propanamide | —— | C15H21NO3S2 |
|
—— | (2S)-2-(3,4-dimethylphenyl)sulfanyl-N-(2-phenylethyl)propanamide | —— | C19H23NOS |
|
—— | (2R)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-tert-butylpropanamide | —— | C15H18BrN3O2S |
|
—— | (2S)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-cyanoethyl)-N-methylpropanamide | —— | C15H15BrN4O2S |
|
—— | (2R)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N,N-di(propan-2-yl)propanamide | —— | C17H22BrN3O2S |
|
—— | (2S)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-propylpropanamide | —— | C14H16BrN3O2S |
|
—— | (2R)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-propylpropanamide | —— | C14H16BrN3O2S |
|
—— | (2R)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methylpropyl)propanamide | —— | C15H18BrN3O2S |
|
—— | (2S)-2-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-tert-butylpropanamide | —— | C15H18BrN3O2S |
|
—— | [(2R)-1-oxo-1-(prop-2-enylamino)propan-2-yl] 2-(4-bromophenyl)sulfanylacetate | —— | C14H16BrNO3S |
|
—— | [(2R)-1-(2-methoxyethylamino)-1-oxopropan-2-yl] 2-(4-bromophenyl)sulfanylacetate | —— | C14H18BrNO4S |
|
—— | [(2S)-1-(2-methylpropylamino)-1-oxopropan-2-yl] 2-(4-bromophenyl)sulfanylacetate | —— | C15H20BrNO3S |
|
—— | [(2S)-1-(methoxycarbonylamino)-1-oxopropan-2-yl] 2-(4-bromophenyl)sulfanylacetate | —— | C13H14BrNO5S |
|
—— | [(2R)-1-[2-cyanoethyl(methyl)amino]-1-oxopropan-2-yl] 2-(4-bromophenyl)sulfanylacetate | —— | C15H17BrN2O3S |
|
—— | [2-oxo-2-(2-phenylsulfanylanilino)ethyl] 2-[(3S)-1,1-dioxothiolan-3-yl]acetate | —— | C20H21NO5S2 |
|
—— | [2-oxo-2-(2-phenylsulfanylanilino)ethyl] 2-[(3R)-1,1-dioxothiolan-3-yl]acetate | —— | C20H21NO5S2 |
|
—— | (3S)-3-(4-propan-2-ylsulfanylphenyl)-3-pyridin-3-ylpropan-1-amine | —— | C17H22N2S |
|
—— | (2R)-N-(2-methylpropyl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C14H23N3OS |
|
—— | (2S)-N-[(2-chlorophenyl)methyl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C17H20ClN3OS |
|
—— | (3S)-3-(4-propan-2-ylsulfanylphenyl)-3-pyridin-2-ylpropan-1-amine | —— | C17H22N2S |
|
—— | (2S)-N-[(4-methylphenyl)methyl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C18H23N3OS |
|
—— | (2R)-N-(propan-2-ylcarbamoyl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C14H22N4O2S |
|
—— | (3R)-3-(4-propan-2-ylsulfanylphenyl)-3-pyridin-2-ylpropan-1-amine | —— | C17H22N2S |
|
—— | (2R)-N-(thiophen-2-ylmethyl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C15H19N3OS2 |
|
—— | (2S)-N-(2-methylpropyl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C14H23N3OS |
|
—— | (3S)-3-(4-propan-2-ylsulfanylphenyl)-3-pyridin-4-ylpropan-1-amine | —— | C17H22N2S |
|
—— | (2R)-N-[(3R)-1,1-dioxothiolan-3-yl]-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylpropanamide | —— | C14H21N3O3S2 |
|